- Home
- AQMS vs CYCN Comparison
AQMS vs CYCN Comparison
Compare AQMS & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQMS
- CYCN
- Stock Information
- Founded
- AQMS 2014
- CYCN 2018
- Country
- AQMS United States
- CYCN United States
- Employees
- AQMS N/A
- CYCN N/A
- Industry
- AQMS Metal Fabrications
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- AQMS Industrials
- CYCN Health Care
- Exchange
- AQMS Nasdaq
- CYCN Nasdaq
- Market Cap
- AQMS 7.7M
- CYCN 6.5M
- IPO Year
- AQMS 2015
- CYCN N/A
- Fundamental
- Price
- AQMS $0.52
- CYCN $2.81
- Analyst Decision
- AQMS Strong Buy
- CYCN
- Analyst Count
- AQMS 3
- CYCN 0
- Target Price
- AQMS $21.00
- CYCN N/A
- AVG Volume (30 Days)
- AQMS 503.6K
- CYCN 21.8K
- Earning Date
- AQMS 08-04-2025
- CYCN 08-06-2025
- Dividend Yield
- AQMS N/A
- CYCN N/A
- EPS Growth
- AQMS N/A
- CYCN N/A
- EPS
- AQMS N/A
- CYCN N/A
- Revenue
- AQMS N/A
- CYCN $2,081,000.00
- Revenue This Year
- AQMS N/A
- CYCN N/A
- Revenue Next Year
- AQMS $550.00
- CYCN N/A
- P/E Ratio
- AQMS N/A
- CYCN N/A
- Revenue Growth
- AQMS N/A
- CYCN N/A
- 52 Week Low
- AQMS $0.51
- CYCN $1.27
- 52 Week High
- AQMS $7.92
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- AQMS 25.92
- CYCN 41.24
- Support Level
- AQMS $0.53
- CYCN $3.02
- Resistance Level
- AQMS $0.83
- CYCN $3.16
- Average True Range (ATR)
- AQMS 0.11
- CYCN 0.21
- MACD
- AQMS -0.01
- CYCN -0.03
- Stochastic Oscillator
- AQMS 1.28
- CYCN 16.26
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.